LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
SNTI
Senti Biosciences, Inc.
There isn't enough reported data to score SNTI yet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
SNTI Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
SNTI's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
SNTI PE Valuation
SNTI has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
SNTI Forward outlook
There aren't enough analyst estimates for SNTI to show an outlook.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over SNTI in the latest year-over-year earnings comparison.
SNTI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$27.34 | -$6.04 |
| Q2 2024 | -$24.43 | -$2.73 |
| Q1 2024 | -$26.18 | -$0.08 |
SNTI is still losing money, but far less than before: $1.79 per share over the past year, against $27.78 at its worst in late 2023.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY's revenue has grown year over year for 14 quarters in a row: $24.4B last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over SNTI on profitability, with a higher operating margin.
SNTI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2023 | $338K | -81% |
| Q2 2023 | $937K | -31% |
| Q4 2022 | $59K | -93% |
| Q4 2021 | $793K | +39550% |
SNTI's revenue has slid since its 2022 peak: $17,000 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -85229% | N/A |
| Q1 2026 | -28850% | N/A |
| Q3 2023 | -12981% | -12014 points |
| Q2 2023 | -2096% | -492 points |
| Q1 2023 | -1542% | N/A |
| Q4 2022 | -33925% | -32553 points |
| Q3 2022 | -967% | N/A |
| Q2 2022 | -1603% | N/A |
SNTI's operating margin was −85229% last quarter, down 83687 points from the same quarter a year ago, near the bottom of its range since 2020.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the stronger cash trend. Its trailing FCF is up 259% versus its history, compared with SNTI at up 34%.
SNTI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$7.5M | +$6.6M |
| Q4 2025 | -$6.9M | +$6.6M |
| Q3 2025 | -$9.4M | -$1.6M |
| Q2 2025 | -$13.3M | -$4.9M |
| Q1 2025 | -$14.1M | -$2.4M |
| Q4 2024 | -$13.5M | -$6.5M |
| Q3 2024 | -$7.9M | +$9.4M |
| Q2 2024 | -$8.3M | +$9M |
SNTI has burned cash in almost every quarter: −$37M over the past year, against −$44M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over SNTI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
SNTI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +173K shares |
| 1 year | +211% | +21.1M shares |
| 3 years | +607% | +26.7M shares |
SNTI has 31M diluted shares, up 211% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
SNTI Net Leverage
SNTI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
SNTI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.7 | Oversold |
| Stochastic | 3.2 | Oversold |
SNTI's weekly RSI is 25 (oversold) and its Stochastic is 3 (oversold).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
SNTI PE vs Healthcare Sector
SNTI has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over SNTI on trend strength, trading above more of its moving averages.
SNTI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.23 | 35% below |
| 20 week MA | $0.38 | 61% below |
| 50 week MA | $0.77 | 81% below |
| 100 week MA | $1.79 | 92% below |
| 200 week MA | $3.87 | 96% below |
SNTI is in a downtrend: it's below all five of its weekly moving averages, and 96% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over SNTI on returns for 2026, with the stronger performance.
SNTI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $100.0 | $98.5 | -1.5% |
| 2022 | $98.5 | $13.4 | -86% |
| 2023 | $13.4 | $6.60 | -51% |
| 2024 | $6.60 | $3.92 | -41% |
| 2025 | $3.92 | $1.06 | -73% |
| 2026 YTD | $1.06 | $0.15 | -86% |
SNTI has finished every year since 2021 lower, and it's down 86% so far in 2026.